DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Pacerone (Amiodarone Hydrochloride) - Published Studies

 
 



Pacerone Related Published Studies

Well-designed clinical trials related to Pacerone (Amiodarone)

Effects of dronedarone started rapidly after amiodarone discontinuation. [2013]

Amiodarone significantly decreases atrial fibrillation in patients undergoing surgery for lung cancer. [2012]

Efficacy and Safety of Celivarone, With Amiodarone as Calibrator, in Patients With an Implantable Cardioverter-Defibrillator for Prevention of Implantable Cardioverter-Defibrillator Interventions or Death: The ALPHEE Study. [2011.11.14]

Pharmacokinetics of intravenous amiodarone and its electrocardiographic effects on healthy Japanese subjects. [2011.05]

A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. [2011.01.18]

A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. [2011]

Metoprolol versus amiodarone in the prevention of atrial fibrillation after cardiac surgery: a randomized trial. [2010.12.07]

[A comparative study on the efficacy and safety of intravenous esmolol, amiodarone and diltiazem for controlling rapid ventricular rate of patients with atrial fibrillation during anesthesia period]. [2010.11]

The effect of amiodarone on cardiac rhythm after cardiopulmonary bypass in patients with atrial fibrillation. [2010.11]

Combination of irbesartan and amiodarone to maintain sinus rhythm in patients with persistent atrial fibrillation after rheumatic valve replacement. [2010.09]

A randomized, controlled study of amiodarone for prevention of atrial fibrillation after transthoracic esophagectomy. [2010.07]

A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. [2010.06.01]

Effect of continuous versus episodic amiodarone treatment on quality of life in persistent atrial fibrillation. [2010.06]

Comparative study of nifekalant versus amiodarone for shock-resistant ventricular fibrillation in out-of-hospital cardiopulmonary arrest patients. [2010.04]

Amiodarone for the prevention of reperfusion ventricular fibrillation. [2010.04]

Perioperative intravenous amiodarone does not reduce the burden of atrial fibrillation in patients undergoing cardiac valvular surgery. [2010.01]

Combination of irbesartan and amiodarone to maintain sinus rhythm in patients with persistent atrial fibrillation after rheumatic valve replacement. [2010]

Low-dose amiodarone for the prevention of atrial fibrillation after coronary artery bypass grafting in patients older than 70 years. [2009.12.20]

Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. [2009.12.01]

Prophylactic amiodarone versus lidocaine for prevention of reperfusion ventricular fibrillation after release of aortic cross-clamp. [2009.12]

Evaluation of the effects of PM101, a cyclodextrin-based formulation of intravenous amiodarone, on blood pressure in healthy humans. [2009.10.15]

Postoperative oral amiodarone versus oral bisoprolol as prophylaxis against atrial fibrillation after coronary artery bypass graft surgery: a prospective randomized trial. [2009.10.02]

Biatrial pacing vs. intravenous amiodarone in prevention of atrial fibrillation after coronary artery bypass surgery. [2009.10.01]

Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. [2009.09.15]

A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection. [2009.09]

The effects of intra-operative amiodarone loading on the systemic inflammatory response syndrome induced by cardiopulmonary bypass. [2009.08]

Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation. [2009.07]

[Comparison of amiodarone plus irbesartan regimen versus amiodarone alone on maintaining sinus rhythm in rheumatic heart disease patients with persistent atrial fibrillation post valve replacement and cardioversion] [2009.06]

[Therapeutic effects of amiodarone and metoprolol on chronic heart failure complicated by ventricular arrhythmia] [2009.06]

Bioequivalence of 2 intravenous amiodarone formulations in healthy participants. [2009.04]

Prevention of atrial fibrillation after coronary artery bypass grafting via atrial electromechanical interval and use of amiodarone prophylaxis. [2009.04]

Ability of amiodarone and propranolol alone or in combination to prevent post-coronary bypass atrial fibrillation. [2009.01]

Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial. [2008.10.15]

Quality of life with defibrillator therapy or amiodarone in heart failure. [2008.09.04]

Combination therapy with amiodarone and enalapril in patients with paroxysmal atrial fibrillation prevents the development of structural atrial remodeling. [2008.07]

Amiodarone protects diabetics and non-diabetics undergoing coronary artery bypass grafting equally. [2008.06]

Amiodarone cost effectiveness in preventing atrial fibrillation after coronary artery bypass graft surgery. [2008.01]

Intravenous and oral administration of amiodarone for the treatment of recent onset atrial fibrillation after digoxin administration. [2007.10.18]

Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation. [2007.10]

A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation. [2007.06.15]

Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter. [2007.06.12]

The safety of amiodarone in patients with heart failure. [2007.06]

Role of amiodarone on the systemic inflammatory response induced by cardiac surgery: proinflammatory actions: [Role de l'amiodarone sur la reaction inflammatoire systemique provoquee par la chirurgie cardiaque : actions pro-inflammatoires]. [2007.04]

Practical regimen for amiodarone use in preventing postoperative atrial fibrillation. [2007.04]

[Comparison between therapeutic effects of acupuncture and intravenous injection of amiodarone in the treatment of paroxymal atrial fibrillation and atrial flutter] [2007.02]

Intravenous and oral amiodarone for the prevention of postoperative atrial fibrillation in patients undergoing off-pump coronary artery bypass surgery. [2007]

Comparative bioavailability study with two amiodarone tablet formulations administered with and without food in healthy subjects. [2007]

Results from the Loire-Ardeche-Drome-Isere-Puy-de-Dome (LADIP) trial on atrial flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter. [2006.10.17]

High dose of amiodarone in a short-term period reduces the incidence of postoperative atrial fibrillation and atrial flutter. [2006.09]

Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial. [2006.07.11]

Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate. [2006.06.07]

Safety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-analysis. [2006.05.01]

Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial. [2006.04]

A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned. [2006.04]

Japanese randomized trial for investigation of a combined therapy of amiodarone and implantable cardioverter defibrillator in patients with ventricular tachycardia and fibrillation: the Nippon ICD Plus Pharmachologic Option Necessity study design. [2006.03]

Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. [2006.01.11]

Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial. [2005.12.28]

Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial. [2005.11.29]

Comparison of acute and long-term effects of single-dose amiodarone and verapamil for the treatment of immediate recurrences of atrial fibrillation after transthoracic cardioversion. [2005.11]

Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis. [2005.09.06]

Effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: a meta-analysis. [2005.09]

Amiodarone versus sotalol for atrial fibrillation. [2005.05.05]

Diltiazem versus amiodarone to prevent atrial fibrillation in coronary surgery. [2005.03]

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. [2005.01.20]

Serial antiarrhythmic therapy: role of amiodarone in prevention of atrial fibrillation recurrence--a lesson from the HOT CAFE Polish Study. [2005]

Effects of amiodarone and thoracic epidural analgesia on atrial fibrillation after coronary artery bypass grafting. [2004.12]

Individual patterns of dynamic QT/RR relationship in survivors of acute myocardial infarction and their relationship to antiarrhythmic efficacy of amiodarone. [2004.10]

Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial. [2004.10]

Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation. [2004.09.01]

Characterization of QT interval adaptation to RR interval changes and its use as a risk-stratifier of arrhythmic mortality in amiodarone-treated survivors of acute myocardial infarction. [2004.09]

Giving IV and oral amiodarone perioperatively for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery: the GAP study. [2004.09]

A pharmacokinetic study of the combined administration of amiodarone and ximelagatran, an oral direct thrombin inhibitor. [2004.09]

Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgery. [2004.08]

Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). [2004.07.13]

Iohexol contrast medium induces QT prolongation in amiodarone patients. [2004.07]

The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death. [2004.07]

Long-term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure: a randomized double-blind study. [2004.04]

Indicators of atrial fibrillation risk in cardiac surgery patients on prophylactic amiodarone. [2004.04]

Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses. [2004.02]

A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation. [2004.01]

Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial. [2004.01]

Cardiac rate normalization in chronic atrial fibrillation: comparison of long-term efficacy of treatment with amiodarone versus AV node ablation and permanent His-bundle pacing. [2004]

Amiodarone versus Implantable Defibrillator (AMIOVIRT): background, rationale, design, methods, results and implications. [2003.12]

Conversion of rheumatic atrial fibrillation by amiodarone after percutaneous balloon mitral commissurotomy. [2003.11.15]

Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II (AFIST II). [2003.09.09]

Amiodarone for the restoration of sinus rhythm in patients with atrial fibrillation. [2003.09]

Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T]). [2003.08.15]

Acute circulatory actions of intravenous amiodarone loading in cardiac surgical patients. [2003.08]

Intravenous amiodarone for cardioversion of recent-onset atrial fibrillation. [2003.07]

Amiodarone prevents symptomatic atrial fibrillation and reduces the risk of cerebrovascular accidents and ventricular tachycardia after open heart surgery: results of the Atrial Fibrillation Suppression Trial (AFIST). [2003.06]

Effect of right atrial pacing, intravenous amiodarone and beta blockers for suppression of atrial fibrillation after coronary artery bypass surgery: a pilot study. [2003.06]

Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting. [2003.06]

Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT. [2003.05.21]

A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation. [2003.05]

Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. [2003.05]

Effects of orlistat, a lipase inhibitor, on the pharmacokinetics of three highly lipophilic drugs (amiodarone, fluoxetine, and simvastatin) in healthy volunteers. [2003.04]

Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study. [2003.04]

Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT). [2003.03]

Pharmacological cardioversion of recent onset atrial fibrillation with intravenous amiodarone in patients receiving long-term amiodarone therapy: is it reasonable? [2003.02]

Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates: a randomized controlled study. [2003.01]

[Role amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation] [2002.12]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017